Swiss Cancer Institute/Incyte HERo in Science Award

Over the past decade, more women than men have graduated from medical school each year, yet women continue to be severely underrepresented in influential clinical research positions. This award aims to support outstanding women who contribute to clinical cancer research in Switzerland, promote scientific excellence and advance equality and innovation.

The prize isendowed with CHF 30'000.– and is intended to promote the continuation of a clinical or translational research project.

Requirements for the candidates

With this scholarship, we offer a funding program specifically for female researchers. The aim is to promote and support their projects and careers in cancer research. The eligible candidates are:

Practicing female physicians who are currently active in clinical and/or translational cancer research in Switzerland
The minimum requirement is a research activity in Switzerland from January 1 to December 31, 2025
There are no age restrictions

Focus

The award is given to a researcher conducting a clinical or translational research project that results in a tangible improvement in patient management and/or outcomes in the field of oncology and hematologic malignancies.

Applications

Applications must be written in English and include the following information:

Project proposal, maximum five pages, including rationale, methodology, feasibility, budget and potential impact
Curriculum vitae of the candidate
Publication list of the candidate
- Publications can be primary research or review articles
- The candidate must be listed as an author in all publications
- Publications must have been published in a peer-reviewed journal in the period 2015-2025 or have been accepted for publication in a peer-reviewed journal
Letter of support from the head of the candidate's current institution, including a guarantee to provide sufficient research time for the project

Submission

Please submit your application by March 31, 2025.

Applications must be submitted electronically to the Swiss Cancer Institute, events@swisscancerinstitute.ch.

In collaboration with Incyte